DOXAPRAM HYDROCHLORIDE (doxapram hydrochloride) by Teva is clinical pharmacology pharmacodynamics doxapram hydrochloride produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. Approved for depression, depression, chronic obstructive pulmonary disease. First approved in 1992.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY Pharmacodynamics Doxapram hydrochloride produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. As the dosage level is increased, the central respiratory centers in the medulla are stimulated with progressive stimulation of other parts of the…
Worked on DOXAPRAM HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.